MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array-Reference-Cited by-同舟云学术

MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array

Published:2014-03-21 Issue:13 Volume:20 Page:3411-3421
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Albiges Laurence,Guegan Justine,Le Formal Audrey,Verkarre Virginie,Rioux-Leclercq Nathalie,Sibony Mathilde,Bernhard Jean-Christophe,Camparo Philippe,Merabet Zahira,Molinie Vincent,Allory Yves,Orear Cedric,Couvé Sophie,Gad Sophie,Patard Jean-Jacques,Escudier Bernard

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma;Journal of Clinical Oncology;2024-09-10

2. Changes in outcome of patients with advanced non-clear cell renal cell carcinoma from the tyrosine kinase inhibitor era to the immuno-oncology era;International Journal of Clinical Oncology;2024-08-14

3. Immunotherapy for renal cell carcinoma: New therapeutic combinations and adverse event management strategies: A review;Medicine;2024-07-26

4. Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma;BJU International;2024-07-16

5. PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort;European Journal of Cancer;2024-07